Notify me when Aisling Capital Management LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 13 | $478,916,332 | +$2,529,360 | -$153,108,650 | -$150,579,290 | BBIO, SNDX, GLUE, BCAX, CMPS | 13F-HR | 10 Feb 2026, 11:05 |
| Q3 2025 | 14 | $456,446,710 | +$12,075,680 | -$1,040,695 | +$11,034,985 | BBIO, VRNA, SNDX, NUVB, GLUE | 13F-HR | 12 Nov 2025, 13:13 |
| Q2 2025 | 13 | $359,671,696 | +$4,981,304 | $0 | +$4,981,304 | BBIO, VRNA, SNDX, GLUE, BCAX | 13F-HR | 13 Aug 2025, 11:11 |
| Q1 2025 | 13 | $288,452,197 | +$669,005 | -$41,806,534 | -$41,137,529 | BBIO, VRNA, SNDX, BCAX, GLUE | 13F-HR | 13 May 2025, 11:19 |
| Q4 2024 | 15 | $281,834,610 | +$796,491 | -$4,056,012 | -$3,259,521 | BBIO, VRNA, SNDX, GLUE, PSTX | 13F-HR | 12 Feb 2025, 16:49 |
| Q3 2024 | 16 | $261,072,335 | +$14,490,367 | $0 | +$14,490,367 | BBIO, VRNA, SNDX, BCAX, BMEA | 13F-HR | 13 Nov 2024, 12:11 |
| Q2 2024 | 15 | $231,052,564 | +$1,385,918 | -$2,240,049 | -$854,131 | BBIO, SNDX, VRNA, ELEV, NUVB | 13F-HR | 08 Aug 2024, 14:56 |
| Q1 2024 | 16 | $295,497,076 | +$2,167,834 | -$51,170 | +$2,116,664 | BBIO, SNDX, VRNA, ELEV, BMEA | 13F-HR | 14 May 2024, 16:08 |
| Q4 2023 | 16 | $335,237,494 | $0 | -$828,652 | -$828,652 | BBIO, VRNA, SNDX, BMEA, CMPS | 13F-HR | 07 Feb 2024, 15:39 |
| Q3 2023 | 17 | $242,681,756 | +$7,965,652 | -$761,864 | +$7,203,788 | BBIO, VRNA, SNDX, BMEA, CMPS | 13F-HR | 13 Nov 2023, 09:58 |
| Q2 2023 | 16 | $204,132,878 | +$974,286 | -$223,143 | +$751,143 | BBIO, VRNA, SNDX, BMEA, GLUE | 13F-HR | 11 Aug 2023, 16:40 |
| Q1 2023 | 16 | $207,812,117 | $0 | -$6,368,315 | -$6,368,315 | BBIO, BMEA, VRNA, SNDX, GLUE | 13F-HR | 09 May 2023, 10:32 |
| Q4 2022 | 16 | $151,470,397 | $0 | -$3,610,000 | -$3,610,000 | BBIO, VRNA, SNDX, GLUE, ACRS | 13F-HR | 09 Feb 2023, 15:26 |
| Q3 2022 | 17 | $150,591,000 | $0 | -$1,375,112 | -$1,375,112 | BBIO, SNDX, VRNA, GLUE, ACRS | 13F-HR | 03 Nov 2022, 17:02 |
| Q2 2022 | 19 | $140,160,000 | $0 | -$18,107,967 | -$18,107,967 | BBIO, SNDX, GLUE, BMEA, ACRS | 13F-HR | 10 Aug 2022, 17:19 |
| Q1 2022 | 21 | $185,304,000 | $0 | -$2,109,641 | -$2,109,641 | BBIO, GLUE, SNDX, HRMY, NUVB | 13F-HR | 10 May 2022, 13:33 |
| Q4 2021 | 21 | $283,454,000 | $0 | -$10,122,806 | -$10,122,806 | BBIO, GLUE, SNDX, NUVB, ELEV | 13F-HR | 18 Feb 2022, 16:04 |
| Q3 2021 | 21 | $501,479,000 | $0 | -$9,582,669 | -$9,582,669 | BBIO, GLUE, NUVB, HRMY, ELEV | 13F-HR | 12 Nov 2021, 09:57 |
| Q2 2021 | 21 | $624,578,000 | +$105,932,000 | $0 | +$105,932,000 | BBIO, ELEV, GLUE, HRMY, NUVB | 13F-HR | 06 Aug 2021, 10:40 |
| Q1 2021 | 15 | $555,604,000 | +$157,479,892 | -$150,319,000 | +$7,160,892 | BBIO, HRMY, NUVB, SNDX, SPRB | 13F-HR | 14 May 2021, 10:43 |
| Q4 2020 | 16 | $582,316,000 | +$29,306,000 | -$4,158,017 | +$25,147,983 | BBIO, EIDX, HRMY, SPRB, SNDX | Restatement | 04 Feb 2021, 17:51 |
| Q3 2020 | 15 | $313,036,000 | +$43,371,863 | -$11,367,000 | +$32,004,863 | BBIO, EIDX, HRMY, SNDX, AVRO | 13F-HR | 10 Nov 2020, 17:40 |
| Q2 2020 | 13 | $262,045,000 | +$5,923,038 | -$4,627,000 | +$1,296,038 | BBIO, EIDX, AVRO, AGLE, SNDX | 13F-HR | 10 Aug 2020, 16:03 |
| Q1 2020 | 14 | $229,556,000 | +$15,871,845 | $0 | +$15,871,845 | BBIO, EIDX, AVRO, SNDX, BCEL | 13F-HR | 11 May 2020, 15:23 |
| Q4 2019 | 13 | $261,004,000 | +$1,048,351 | $0 | +$1,048,351 | BBIO, EIDX, AVRO, AGLE, BCEL | 13F-HR | 06 Feb 2020, 12:09 |
| Q3 2019 | 13 | $191,825,000 | +$3,146,917 | -$12,021,000 | -$8,874,083 | BBIO, EIDX, AVRO, OBSVF, MRKR | 13F-HR | 13 Nov 2019, 12:06 |
| Q2 2019 | 14 | $234,139,000 | +$112,634,460 | $0 | +$112,634,460 | BBIO, EIDX, MRKR, OBSVF, AVRO | Restatement | 13 Aug 2019, 14:48 |
| Q1 2019 | 12 | $131,269,000 | +$10,564,629 | -$2,537,518 | +$8,027,111 | EIDX, AVRO, OBSVF, BHVN, MRKR | 13F-HR | 20 May 2019, 17:24 |
| Q4 2018 | 12 | $94,914,000 | $0 | $0 | $0 | OBSVF, EIDX, AVRO, MRKR, BHVN | 13F-HR | 08 Feb 2019, 14:26 |